Analytical Data
-
Gene name
SAT2
- Application
-
Alternative Names
SAT2;SSAT2;Thialysine N-epsilon-acetyltransferase
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q502X4
-
Expression Region
1-190aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MASVRIREAK EGDCGDILRL IRELAEFEKL SDQVKISEEA LRADGFGDNP FYHCLVAEIL PAPGKLLGPC VVGYGIYYFI YSTWKGRTIY LEDIYVMPEY RGQGIGSKII KKVAEVALDK GCSQFRLAVL DWNQRAMDLY KALGAQDLTE AEGWHFFCFQ GEATRKLAGK
-
Molecular Weight
21 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SAT2 (Staphylococcus aureus protein 2) is a recombinant protein that has garnered attention in the fields of microbiology and immunology due to its potential applications in vaccine development and therapeutic interventions. Staphylococcus aureus, a major pathogen responsible for various infections, has evolved mechanisms to evade host immune responses, making it a significant concern in healthcare settings. The study of SAT2 focuses on understanding its structure, function, and interaction with host immune mechanisms. Research indicates that SAT2 plays a role in modulating immune responses, which could be harnessed to enhance vaccine efficacy or develop novel therapeutic strategies. Recent advancements in recombinant DNA technology allow for the production of SAT2 in a controlled laboratory environment, facilitating in-depth studies on its immunogenic properties and potential as a vaccine candidate. Ongoing research aims to elucidate the precise role of SAT2 in the pathogenesis of Staphylococcus aureus infections and to explore its potential in conjunction with other antigens or adjuvants to improve immune responses. As antibiotic resistance in Staphylococcus aureus continues to rise, understanding and leveraging proteins like SAT2 may provide critical insights and tools for combating infections more effectively.











